# KreaMedica

KreaMedica is an Asset Manager based in Montreal, Canada.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Montreal, Canada
- **Region:** North America
- **Address:** 7236 Waverly Street Montreal, Quebec, H2R 0C2 CANADA
- **Assets under management:** Undisclosed
- **Website:** kreamedica.com
- **LinkedIn:** https://www.linkedin.com/company/kreamedica-inc

## Regulatory record

- **Reports private funds:** No

## About

KreaMedica: The premier biotechnology consulting company and outsourcing partner for all your biotech project needs.

## Sectors

- Biotech

## Offices

- Oakland, CA
- Palo Alto, CA
- Seoul, South Korea
- Tel Aviv, Israel

## People

- Karl-Rudolf Erlemann — Leadership Team
- Vik Pham — Leadership Team
- Christina Wizemann — Leadership Team
- Francois Duguay — Leadership Team
- Dominic Poulin — Leadership Team

## Questions

### How does KreaMedica structure its engagements with biotech sponsors?

The firm positions itself as a general contractor rather than a traditional consulting agency. It identifies suitable CRO and CMO vendors, prepares and manages budgets, oversees daily monitoring, and delivers a submission-ready package upon program completion. Clients retain strategic control while KreaMedica absorbs operational and vendor-management accountability.

### What therapeutic areas does KreaMedica specialize in?

Its website highlights deep expertise in biologics, inhalation drug delivery, vaccine development, and CNS therapeutics. These areas involve complex pharmacology, unique regulatory pathways, and specialized CRO networks — which aligns with KreaMedica's model of assembling fit-for-purpose vendor teams rather than applying a one-size-fits-all approach.

### What is KreaConnect, and how does it supplement KreaMedica's core services?

KreaConnect is an on-demand expert marketplace integrated into KreaMedica's offering. It gives clients rapid access to vetted consultants in regulatory affairs, CMC, pharmacology, toxicology, and clinical strategy. This allows sponsors to fill precise expertise gaps without adding permanent headcount, directly reinforcing the firm's lean virtual-team philosophy.

### Who leads KreaMedica, and what is their professional background?

The firm's website identifies a five-person leadership team: Karl-Rudolf Erlemann (Ph.D.), Vik Pham (B.Sc.), Christina Wizemann, Francois Duguay, and Dominic Poulin (M.Sc.). Specific prior roles and career histories are not detailed on the site, and the firm does not assign formal titles beyond Leadership Team membership.

### Does KreaMedica invest capital into its biotech clients, or is it purely a service provider?

The website states that KreaMedica has invested in biotech companies at the seed and Series A stages, but it provides no details on fund size, check size, or investment vehicle structure. The firm does not position itself as a dedicated venture investor, and its core disclosed activity remains fee-for-service drug-development outsourcing.

## Related profiles

- [Parkman Healthcare Partners](https://altss.com/profile/parkman-healthcare-partners)
- [Evolve Media Holdings](https://altss.com/profile/evolve-media-holdings)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/kreamedica-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology